Risk assessment and management of high risk familial breast cancer

被引:40
作者
Evans, DGR
Lalloo, F
机构
[1] Univ Manchester, St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England
[2] Univ Manchester, St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England
关键词
D O I
10.1136/jmg.39.12.865
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
The demand for genetic services by women with a family history of breast cancer has increased exponentially over the last few years. It is important that risks to women are accurately assessed and that processes are in place for appropriate counselling and management. The classification of risk into average, moderate, and high, depending upon the assessed lifetime risk of breast cancer, allows for the management of moderate risk women within cancer units and high risk women within the regional genetic centres. Management of high risk women includes discussion of options including screening, chemoprevention, and preventive surgery. The majority of these options are still unproven in the long term and continuing research is needed for their evaluation. Mutation screening and predictive testing are now a reality for a minority of families, allowing for a more informed basis for decisions regarding management options.
引用
收藏
页码:865 / 871
页数:7
相关论文
共 97 条
[1]
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes [J].
Antoniou, AC ;
Pharoah, PDP ;
McMullan, G ;
Day, NE ;
Stratton, MR ;
Peto, J ;
Ponder, BJ ;
Easton, DF .
BRITISH JOURNAL OF CANCER, 2002, 86 (01) :76-83
[2]
Baxter N, 2001, CAN MED ASSOC J, V164, P1837
[3]
Graphs to estimate an individualized risk of breast cancer [J].
Benichou, J ;
Gail, MH ;
Mulvihill, JJ .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :103-110
[4]
Berglund A, 2000, ANN ZOOL FENN, V37, P1
[5]
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].
Brekelmans, CTM ;
Seynaeve, C ;
Bartels, CCM ;
Tilanus-Linthorst, MMA ;
Meijers-Heijboer, EJ ;
Crepin, CMG ;
van Geel, AN ;
Menke, M ;
Verhoog, LC ;
van den Ouweland, A ;
Obdeijn, IM ;
Klijn, JGM .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930
[6]
Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study [J].
Brown, J ;
Buckley, D ;
Coulthard, A ;
Dixon, AK ;
Dixon, JM ;
Easton, DF ;
Eeles, RA ;
Evans, DGR ;
Gilbert, FG ;
Graves, M ;
Hayes, C ;
Jenkins, JPR ;
Jones, AP ;
Keevil, SF ;
Leach, MO ;
Liney, GP ;
Moss, SM ;
Padhani, AR ;
Parker, GJM ;
Pointon, LJ ;
Ponder, BAJ ;
Redpath, TW ;
Sloane, JP ;
Turnbull, LW ;
Walker, LG ;
Warren, RML .
MAGNETIC RESONANCE IMAGING, 2000, 18 (07) :765-776
[7]
Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5
[8]
WOMENS RECEPTIVITY TO TESTING FOR A GENETIC SUSCEPTIBILITY TO BREAST-CANCER [J].
CHALIKI, H ;
LOADER, S ;
LEVENKRON, JC ;
LOGANYOUNG, W ;
HALL, WJ ;
ROWLEY, PT .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1995, 85 (08) :1133-1135
[9]
FAMILY HISTORY AND BILATERAL PRIMARY BREAST-CANCER [J].
CHAUDARY, MA ;
MILLIS, RR ;
BULBROOK, RD ;
HAYWARD, JL .
BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (02) :201-205
[10]
Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205